Federal action this year has tightened the rules around gender-affirming care in ways that could make it harder for many people to get everyday supports and clinical treatments. Two separate-but-related shifts are prompting alarm among advocates, clinicians and the people who rely on these services: the Food and Drug Administration’s scrutiny of chest-compression garments (commonly called binders) and the Bureau of Prisons’ new restrictions on gender-affirming medical care in custody. Together, those moves are changing how community clinics, suppliers and correctional health systems manage treatment — and raising real concerns about access, safety and continuity of care.
Why binders are in the regulatory spotlight
Binders are often a first-line, low-risk way for trans and nonbinary people to reduce chest prominence and relieve gender-related distress. For many, a well-fitting, purpose-made binder makes it easier to leave the house, go to work, and participate in daily life without acute dysphoria. Community groups and donation networks treat them as essential items and routinely pair distributions with safety guidance: how a proper fit should feel, why you shouldn’t sleep in a binder, and when to seek medical help.
The FDA’s recent warnings to some manufacturers and retailers focus on marketing language. Regulators say that if a seller advertises a binder as a treatment for gender dysphoria, that claim could bring the product under federal medical-device rules. The agency cited evidence that prolonged binding can cause musculoskeletal pain and breathing difficulties, even as compression also appears to reduce psychological distress for some users. Policymakers and companies are now wrestling with a tough question: how to curtail real safety risks without cutting off access to a product many people depend on.
Practical fixes that clinicians and rights groups suggest include commissioning independent clinical reviews, clarifying intended use in advertising, and developing voluntary design and labeling standards. That might mean clearer fit guidance, recommended limits on continuous wear, and warnings for people with certain health conditions. The aim is to reduce harm while keeping commercially produced, purpose-built options widely available.
Community practices and harm reduction
Grassroots organizations have filled much of the gap left by formal systems. Donation drives and peer networks not only supply binders but also provide hands-on education about safer use. That outreach significantly lowered injury rates compared with the era when people improvised compression with ACE bandages or duct tape — methods that are more likely to cause soft-tissue damage, rib injury or breathing problems.
Legal and public-health advocates argue regulators need to be transparent and proportionate: publish clear criteria for when a product crosses into medical-device territory, encourage voluntary testing, and allow for industry standards that document safety. Those steps would help preserve access to low-risk, commercially produced garments while addressing legitimate safety concerns.
What’s happening behind bars
The Bureau of Prisons has tightened rules that limit most forms of gender-affirming medical care for people diagnosed with gender dysphoria. Those policy changes affect access to hormone therapy, referrals for specialty care and, in some cases, basic items like binders. Advocates warn that restricting access in custody settings could force incarcerated people into riskier practices or make them abruptly stop binding, with likely physical and mental-health consequences: increased anxiety, breathing trouble, and pain from unsafe compression techniques.
Correctional-health experts emphasize that harm can be reduced with sensible protocols rather than blanket bans. Recommended measures include allowing medically approved binders, performing individualized health screenings, offering guidance on safe use, ensuring secure storage and laundering, and training staff about harm-reduction practices. Independent medical review panels for disputed cases and clear separation of security rules from medical decision-making would also help preserve continuity of care when people enter or leave detention.
What advocates and clinicians are pushing for
Across settings, clinicians and advocates want policies that balance safety with access. Specific requests include:
- – Clear clinical guidance that keeps medical decisions separate from custody security rules.
- Protocols to ensure continuity of care at intake and upon release.
- Mandatory training for correctional health staff and timely access to independent medical review in contested cases.
- Published regulatory criteria about which products or claims trigger medical-device oversight, plus expedited channels for medical exceptions.
- Routine data collection on treatment interruptions and associated harms to inform future policy.
Broader implications
These regulatory and custodial changes have ripple effects beyond any single clinic or prison. Suppliers may alter how they market and label products; community organizations could face greater demand as people look for alternatives; and health systems may need new workflows to document and justify what they provide. If officials opt for heavy-handed restrictions without clear, evidence-based safety standards and accessible exceptions, the most likely outcome is increased disruption of existing care — with the greatest impact on people who are already marginalized.
Why binders are in the regulatory spotlight
Binders are often a first-line, low-risk way for trans and nonbinary people to reduce chest prominence and relieve gender-related distress. For many, a well-fitting, purpose-made binder makes it easier to leave the house, go to work, and participate in daily life without acute dysphoria. Community groups and donation networks treat them as essential items and routinely pair distributions with safety guidance: how a proper fit should feel, why you shouldn’t sleep in a binder, and when to seek medical help.0